Anticoagulation control in atrial fibrillation patients with chronic kidney disease receiving warfarin for stroke prevention: The west Birmingham AF project

2021 ◽  
Vol 345 ◽  
pp. 17
Author(s):  
H.H. Zulkifly ◽  
G.Y.H. Lip ◽  
D.A. Lane
Keyword(s):  
Atrial Fibrillation ◽  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Stroke Prevention ◽  
The West ◽  
Anticoagulation Control

Non-Vitamin K Oral Anticoagulant Drugs for Stroke Prevention in Patients with Atrial Fibrillation and Chronic Kidney Disease

2016 ◽  
Vol 23 (19) ◽  
pp. 2055-2069 ◽  
Author(s):  
Tatjana S. Potpara ◽  
Vera Jokic ◽  
Nikolaos Dagres ◽  
Torben B. Larsen ◽  
Deirdre A. Lane ◽  
...  
Keyword(s):  
Atrial Fibrillation ◽  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Vitamin K ◽  
Stroke Prevention ◽  
Oral Anticoagulant ◽  
Anticoagulant Drugs

Stroke Prevention in Atrial Fibrillation Patients With Chronic Kidney Disease

2013 ◽  
Vol 29 (7) ◽  
pp. S71-S78 ◽  
Author(s):  
Robert G. Hart ◽  
John W. Eikelboom ◽  
K. Scott Brimble ◽  
M. Sean McMurtry ◽  
Alistair J. Ingram
Keyword(s):  
Atrial Fibrillation ◽  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Stroke Prevention

scholarly journals Warfarin utilisation and anticoagulation control in patients with atrial fibrillation and chronic kidney disease

Heart ◽  
2016 ◽  
Vol 103 (11) ◽  
pp. 818-826 ◽  
Author(s):  
Felix Yang ◽  
Jessica A Hellyer ◽  
Claire Than ◽  
Aditya J Ullal ◽  
Daniel W Kaiser ◽  
...  
Keyword(s):  
Atrial Fibrillation ◽  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Anticoagulation Control

Pathophysiology of atrial fibrillation and chronic kidney disease

2020 ◽  
Author(s):  
Wern Yew Ding ◽  
Dhiraj Gupta ◽  
Christopher F Wong ◽  
Gregory Y H Lip
Keyword(s):  
Risk Factors ◽  
Atrial Fibrillation ◽  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Oral Anticoagulation ◽  
Stroke Prevention ◽  
Bleeding Complications ◽  
Stroke Management ◽  
Underlying Mechanisms ◽  
Shared Risk

Abstract Atrial fibrillation (AF) and chronic kidney disease (CKD) are closely related conditions with shared risk factors. The growing prevalence of both AF and CKD indicates that more patients will suffer from concurrent conditions. There are various complex interlinking mechanisms with important implications for the management of these patients. Furthermore, there is uncertainty regarding the use of oral anticoagulation (OAC) in AF and CKD that is reflected by a lack of consensus between international guidelines. Therefore, the importance of understanding the implications of co-existing AF and CKD should not be underestimated. In this review, we discuss the pathophysiology and association between AF and CKD, including the underlying mechanisms, risk of thrombo-embolic and bleeding complications, influence on stroke management, and evidence surrounding the use of OAC for stroke prevention.

The Problem of Atrial Fibrillation in Patients with Chronic Kidney Disease

2016 ◽  
Vol 14 (3) ◽  
pp. 260-265 ◽  
Author(s):  
Beata Franczyk ◽  
Anna Gluba-Brzózka ◽  
Aleksandra Cia|kowska-Rysz ◽  
Maciej Banach ◽  
Jacek Rysz
Keyword(s):  
Atrial Fibrillation ◽  
Chronic Kidney Disease ◽  
Kidney Disease
Sign in / Sign up

Export Citation Format

Share Document